Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Acelyrin Inc (NQ: SLRN ) 4.970 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Aug 8, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 200 Open 4.970 Bid (Size) 4.340 (3) Ask (Size) 6.800 (6) Prev. Close 4.970 Today's Range 4.970 - 4.970 52wk Range 3.670 - 29.88 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News ACELYRIN, INC. to Report Second Quarter 2024 Financial Results and Corporate Update on August 13, 2024 August 06, 2024 From ACELYRIN, INC. Via GlobeNewswire Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session July 08, 2024 Via Benzinga Performance YTD -37.41% -37.41% 1 Month -2.55% -2.55% 3 Month +1.84% +1.84% 6 Month -39.32% -39.32% 1 Year -80.51% -80.51% More News Read More ACELYRIN, INC. Announces Positive 16-week Data From its Global Phase 2b/3 Trial of Izokibep in Psoriatic Arthritis to be Shared During Late-Breaking Oral Presentation at EULAR 2024 June 05, 2024 From ACELYRIN, INC. Via GlobeNewswire ACELYRIN, INC. Announces Lonigutamab Phase 1/2 Proof-Of-Concept Data to be Shared During Late-Breaking Oral Presentation at ENDO 2024 May 29, 2024 From ACELYRIN, INC. Via GlobeNewswire ACELYRIN ALERT: Bragar Eagel & Squire, P.C. is Investigating Acelyrin, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm May 17, 2024 From Bragar Eagel & Squire Via GlobeNewswire SLRN Stock Earnings: Acelyrin Beats EPS for Q1 2024 May 15, 2024 Via InvestorPlace ACELYRIN, INC. Provides Business Update and Highlights Key Upcoming Milestones May 09, 2024 From ACELYRIN, INC. Via GlobeNewswire SLRN Stock Earnings: Acelyrin Beats EPS for Q4 2023 March 28, 2024 Via InvestorPlace ACELYRIN, INC. Announces Leadership Transition May 09, 2024 From ACELYRIN, INC. Via GlobeNewswire ACELYRIN, INC. to Report First Quarter 2024 Financial Results and Corporate Update on May 13, 2024 April 29, 2024 From ACELYRIN, INC. Via GlobeNewswire ACELYRIN, INC. Reports Full Year 2023 Financial Results and Recent Highlights March 28, 2024 From ACELYRIN, INC. Via GlobeNewswire Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million March 27, 2024 From Avalo Therapeutics Via GlobeNewswire Investors Cheer Acelyrin's Stock, Its Second Lead Candidate Shows Clinical Benefit In Thyroid Eye Disease Patients March 20, 2024 Via Benzinga ACELYRIN, INC. Announces Positive Phase 1/2 Proof-of-Concept Data for Lonigutamab, First Subcutaneous Anti-IGF-1R to Demonstrate Clinical Responses in Thyroid Eye Disease March 20, 2024 From ACELYRIN, INC. Via GlobeNewswire Acelyrin's Lead Drug Candidate Hits Primary Goal In Late-Stage Psoriatic Arthritis Study March 11, 2024 Via Benzinga ACELYRIN, INC. Announces Positive Top-line Results from Its Global Phase 2b/3 Clinical Trial of Izokibep in Psoriatic Arthritis March 11, 2024 From ACELYRIN, INC. Via GlobeNewswire ACELYRIN, INC. Announces Long-term 32-Week Data from the Phase 2b Trial of Izokibep in Hidradenitis Suppurativa Demonstrating Sustained Responses and Deepening Clinical Benefit - Improving Quality of Life for Patients March 11, 2024 From ACELYRIN, INC. Via GlobeNewswire ACELYRIN, INC. Appoints Agnes Lee as Senior Vice President, Investor Relations and Corporate Communications February 15, 2024 From ACELYRIN, INC. Via GlobeNewswire Acelyrin (SLRN) Investor Update: Kaplan Fox & Kilsheimer LLP Reminds Acelyrin Investors of a Class Action Lawsuit and Upcoming Deadline January 16, 2024 Via NewMediaWire Topics Lawsuit Exposures Financial Legal SLRN DEADLINE TOMORROW: ROSEN, A LEADING NATIONAL FIRM, Encourages ACELYRIN, INC. Investors with Losses to Secure Counsel Before Important January 16 Deadline in Securities Class Action - SLRN January 15, 2024 Via NewMediaWire Topics Lawsuit Exposures Financial Legal SLRN DEADLINE NOTICE: ROSEN, A LONGSTANDING LAW FIRM, Encourages ACELYRIN, INC. Investors to Secure Counsel Before Important January 16 Deadline in Securities Class Action - SLRN January 14, 2024 Via NewMediaWire Topics Lawsuit Exposures Financial Legal SLRN DEADLINE NOTICE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages ACELYRIN, INC. Investors with Losses to Secure Counsel Before Important January 16 Deadline in Securities Class Action - SLRN January 13, 2024 Via NewMediaWire Topics Lawsuit Exposures Financial Legal ACELYRIN DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Acelyrin, Inc. and Encourages Investors to Contact the Firm January 12, 2024 From Bragar Eagel & Squire Via GlobeNewswire SLRN IMPORTANT DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages ACELYRIN, INC. Investors to Secure Counsel Before Important January 16 Deadline in Securities Class Action SLRN January 12, 2024 Via NewMediaWire Topics Lawsuit Exposures Financial Legal SLRN DEADLINE NOTICE: ROSEN, LEADING INVESTOR COUNSEL, Encourages ACELYRIN, INC. Investors with Losses in Excess of $100k to Secure Counsel Before Important January 16 Deadline in Securities Class Action - SLRN January 11, 2024 Via NewMediaWire Topics Lawsuit Exposures Financial Legal Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
